• Find People
  • Campus Map
  • PiratePort
  • A-Z
    • About
    • Submit
    • Browse
    • Login
    View Item 
    •   ScholarShip Home
    • Other Campus Research
    • Open Access
    • View Item
    •   ScholarShip Home
    • Other Campus Research
    • Open Access
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of The ScholarShipCommunities & CollectionsDateAuthorsTitlesSubjectsTypeDate SubmittedThis CollectionDateAuthorsTitlesSubjectsTypeDate Submitted

    My Account

    Login

    Statistics

    View Google Analytics Statistics

    Decreased CD8+CD28+/CD8+CD28– T cell ratio can sensitively predict poor outcome for patients with complicated Crohn disease

    Thumbnail
    View/ Open
    medi-96-e7247.pdf (856.0Kb)

    Show full item record
    
    Author
    Dai, Shi-xue; Gu, Hong-xiang; Lin, Qian-yi; Wu, Yan-kun; Wang, Xiao-yan; Huang, Shao-zhuo; Xing, Tiao-si; Chen, Min-hua; Zhang, Qing-fang; Zheng, Zhong-wen; Sha, Wei-hong
    Abstract
    Crohn disease (CD) with complications such as penetrating, stricturing, and perianal disease is called complicated CD. The aim of this study is to test the efficiency with which the CD8+CD28+/CD8+CD28– cell balance can predict a subsequent active stage in patients with newly diagnosed complicated CD. Seventeen patients with complicated CD and 48 CD patients with no complications were enrolled. Blood CD8+ T cells were tested from all of the 65 newly diagnosed CD patients upon enrollment. The potential risk factors were compared between the 2 groups. A 30-week follow-up was performed, and the efficiency of the CD8+ cell balance at predicting active CD was analyzed using receiver- operating characteristic curves. The cumulative remission lasting rates (CRLRs) were analyzed using the Kaplan–Meier method. Compared with the control CD group, patients with complicated CD were predominantly male and younger in age; they also had lower body mass indices (BMIs), higher Crohn disease activity indices (CDAIs), higher immunosuppressant and steroid prescription rates, and significantly higher surgical rates. The CD8+CD28+/CD8+CD28– balance was associated with BMI, CDAI, steroids, and surgery. The CD8+CD28+/CD8+CD28– ratios were significantly lower at week 0 and on the 6th, 22nd, and 30th week during follow- up with a shorter lasting time of remission for the complicated CD patients. The CD8+CD28+/CD8+CD28– ratio could accurately predict the active stage for the patients with complicated CD, and the highest sensitivity (89.2%) and specificity (85.3%) were found when the ratio was 1.03. Treatment with steroids and surgery, along with a significantly lower CD8+CD28+/CD8+CD28– ratio and lower CRLRs, was closely related to a worse outcome for the patients with complicated CD. Patients requiring steroids and surgery experience more severe disease activity and thus a disequilibrated immunological balance, which could be the main reason for a decreased CD8+CD28+/CD8+CD28– ratio. This ratio can sensitively predict the active stage for patients with complicated CD, and more care should be taken when this ratio is <1.03.
    URI
    http://hdl.handle.net/10342/8151
    Date
    2017-06
    Citation:
    APA:
    Dai, Shi-xue, & Gu, Hong-xiang, & Lin, Qian-yi, & Wu, Yan-kun, & Wang, Xiao-yan, & Huang, Shao-zhuo, & Xing, Tiao-si, & Chen, Min-hua, & Zhang, Qing-fang, & Zheng, Zhong-wen, & Sha, Wei-hong. (June 2017). Decreased CD8+CD28+/CD8+CD28– T cell ratio can sensitively predict poor outcome for patients with complicated Crohn disease. Medicine, (96:26), p.. Retrieved from http://hdl.handle.net/10342/8151

    Display/Hide MLA, Chicago and APA citation formats.

    MLA:
    Dai, Shi-xue, and Gu, Hong-xiang, and Lin, Qian-yi, and Wu, Yan-kun, and Wang, Xiao-yan, and Huang, Shao-zhuo, and Xing, Tiao-si, and Chen, Min-hua, and Zhang, Qing-fang, and Zheng, Zhong-wen, and Sha, Wei-hong. "Decreased CD8+CD28+/CD8+CD28– T cell ratio can sensitively predict poor outcome for patients with complicated Crohn disease". Medicine. 96:26. (.), June 2017. April 19, 2021. http://hdl.handle.net/10342/8151.
    Chicago:
    Dai, Shi-xue and Gu, Hong-xiang and Lin, Qian-yi and Wu, Yan-kun and Wang, Xiao-yan and Huang, Shao-zhuo and Xing, Tiao-si and Chen, Min-hua and Zhang, Qing-fang and Zheng, Zhong-wen and Sha, Wei-hong, "Decreased CD8+CD28+/CD8+CD28– T cell ratio can sensitively predict poor outcome for patients with complicated Crohn disease," Medicine 96, no. 26 (June 2017), http://hdl.handle.net/10342/8151 (accessed April 19, 2021).
    AMA:
    Dai, Shi-xue, Gu, Hong-xiang, Lin, Qian-yi, Wu, Yan-kun, Wang, Xiao-yan, Huang, Shao-zhuo, Xing, Tiao-si, Chen, Min-hua, Zhang, Qing-fang, Zheng, Zhong-wen, Sha, Wei-hong. Decreased CD8+CD28+/CD8+CD28– T cell ratio can sensitively predict poor outcome for patients with complicated Crohn disease. Medicine. June 2017; 96(26) . http://hdl.handle.net/10342/8151. Accessed April 19, 2021.
    Collections
    • Open Access

    xmlui.ArtifactBrowser.ItemViewer.elsevier_entitlement

    East Carolina University has created ScholarShip, a digital archive for the scholarly output of the ECU community.

    • About
    • Contact Us
    • Send Feedback